Clinical investigation observes the impact of GLP-1 receptor agonists on chronic ocular diseases, highlighting implications for age-related macular degeneration management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Allan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: